• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过生长竞争试验对1型人类免疫缺陷病毒体外实验中的复制适应性进行建模和估计。

Modeling and estimation of replication fitness of human immunodeficiency virus type 1 in vitro experiments by using a growth competition assay.

作者信息

Wu Hulin, Huang Yangxin, Dykes Carrie, Liu Dacheng, Ma Jingming, Perelson Alan S, Demeter Lisa M

机构信息

Department of Biostatistics and Computational Biology, University of Rochester School of Medicine and Dentistry, New York 14642, USA.

出版信息

J Virol. 2006 Mar;80(5):2380-9. doi: 10.1128/JVI.80.5.2380-2389.2006.

DOI:10.1128/JVI.80.5.2380-2389.2006
PMID:16474144
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1395363/
Abstract

Growth competition assays have been developed to quantify the relative fitnesses of human immunodeficiency virus (HIV-1) mutants. In this article we develop mathematical models to describe viral/cellular dynamic interactions in the assay experiment, from which new competitive fitness indices or parameters are defined. These indices include the log fitness ratio (LFR), the log relative fitness (LRF), and the production rate ratio (PRR). From the population genetics perspective, we clarify the confusion and correct the inconsistency in the definition of relative fitness in the literature of HIV-1 viral fitness. The LFR and LRF are easier to estimate from the experimental data than the PRR, which was misleadingly defined as the relative fitness in recent HIV-1 research literature. Calculation and estimation methods based on two data points and multiple data points were proposed and were carefully studied. In particular, we suggest using both standard linear regression (method of least squares) and a measurement error model approach for more-accurate estimates of competitive fitness parameters from multiple data points. The developed methodologies are generally applicable to any growth competition assays. A user-friendly computational tool also has been developed and is publicly available on the World Wide Web at http://www.urmc.rochester.edu/bstools/vfitness/virusfitness.htm.

摘要

已经开发出生长竞争试验来量化人类免疫缺陷病毒(HIV-1)突变体的相对适应性。在本文中,我们建立数学模型来描述试验实验中的病毒/细胞动态相互作用,并据此定义新的竞争适应性指数或参数。这些指数包括对数适应性比(LFR)、对数相对适应性(LRF)和生产率比(PRR)。从群体遗传学的角度,我们澄清了HIV-1病毒适应性文献中相对适应性定义的混乱并纠正了不一致之处。与PRR相比,LFR和LRF更容易从实验数据中估计,而PRR在最近的HIV-1研究文献中被错误地定义为相对适应性。我们提出并仔细研究了基于两个数据点和多个数据点的计算和估计方法。特别是,我们建议使用标准线性回归(最小二乘法)和测量误差模型方法,以便从多个数据点更准确地估计竞争适应性参数。所开发的方法通常适用于任何生长竞争试验。我们还开发了一个用户友好的计算工具,可在万维网http://www.urmc.rochester.edu/bstools/vfitness/virusfitness.htm上公开获取。

相似文献

1
Modeling and estimation of replication fitness of human immunodeficiency virus type 1 in vitro experiments by using a growth competition assay.通过生长竞争试验对1型人类免疫缺陷病毒体外实验中的复制适应性进行建模和估计。
J Virol. 2006 Mar;80(5):2380-9. doi: 10.1128/JVI.80.5.2380-2389.2006.
2
vFitness: a web-based computing tool for improving estimation of in vitro HIV-1 fitness experiments.vFitness:一个基于网络的计算工具,用于改进 HIV-1 体外适应度实验的估计。
BMC Bioinformatics. 2010 May 18;11:261. doi: 10.1186/1471-2105-11-261.
3
Modeling and estimation of kinetic parameters and replicative fitness of HIV-1 from flow-cytometry-based growth competition experiments.基于流式细胞术的生长竞争实验对HIV-1动力学参数和复制适应性的建模与估计
Bull Math Biol. 2008 Aug;70(6):1749-71. doi: 10.1007/s11538-008-9323-4. Epub 2008 Jul 22.
4
Estimating relative fitness in viral competition experiments.在病毒竞争实验中估计相对适应性。
J Virol. 2000 Dec;74(23):11067-72. doi: 10.1128/jvi.74.23.11067-11072.2000.
5
Methods to determine HIV-1 ex vivo fitness.测定HIV-1体外适应性的方法。
Methods Mol Biol. 2005;304:355-68. doi: 10.1385/1-59259-907-9:355.
6
Pairwise growth competition assay for determining the replication fitness of human immunodeficiency viruses.用于确定人类免疫缺陷病毒复制适应性的成对生长竞争试验。
J Vis Exp. 2015 May 4(99):e52610. doi: 10.3791/52610.
7
Factors affecting relative fitness measurements in pairwise competition assays of human immunodeficiency viruses.影响人类免疫缺陷病毒成对竞争分析中相对适合度测量的因素。
J Virol Methods. 2013 Dec;194(1-2):7-13. doi: 10.1016/j.jviromet.2013.07.062. Epub 2013 Aug 8.
8
Procedures for reliable estimation of viral fitness from time-series data.从时间序列数据可靠估计病毒适应性的方法。
Proc Biol Sci. 2002 Sep 22;269(1503):1887-93. doi: 10.1098/rspb.2002.2097.
9
Evaluation of a multiple-cycle, recombinant virus, growth competition assay that uses flow cytometry to measure replication efficiency of human immunodeficiency virus type 1 in cell culture.一种多周期重组病毒生长竞争试验的评估,该试验使用流式细胞术来测量1型人类免疫缺陷病毒在细胞培养中的复制效率。
J Clin Microbiol. 2006 Jun;44(6):1930-43. doi: 10.1128/JCM.02415-05.
10
Human immunodeficiency virus type 1 fitness and tropism: concept, quantification, and clinical relevance.人类免疫缺陷病毒 1 型的适应性和嗜性:概念、定量和临床相关性。
Clin Microbiol Infect. 2010 Oct;16(10):1532-8. doi: 10.1111/j.1469-0691.2010.03335.x.

引用本文的文献

1
A Novel High Throughput, Parallel Infection Assay for Determining the Replication Capacities of 346 Primary HIV-1 Isolates of the Zurich Primary HIV-1 Infection Study in Primary Cells.一种新型高通量、平行感染测定法,用于测定苏黎世原发性 HIV-1 感染研究中 346 株原发性 HIV-1 分离株在原代细胞中的复制能力。
Viruses. 2021 Mar 4;13(3):404. doi: 10.3390/v13030404.
2
"Submergence" of Western equine encephalitis virus: Evidence of positive selection argues against genetic drift and fitness reductions.西方马脑炎病毒的“淹没”:正选择的证据表明遗传漂变和适应性降低的可能性较小。
PLoS Pathog. 2020 Feb 6;16(2):e1008102. doi: 10.1371/journal.ppat.1008102. eCollection 2020 Feb.
3
Accumulated mutations by 6 months of infection collectively render transmitted/founder HIV-1 significantly less fit.在感染 6 个月时累积的突变使传播/原始 HIV-1 显著适应性降低。
J Infect. 2020 Feb;80(2):210-218. doi: 10.1016/j.jinf.2019.12.001. Epub 2019 Dec 5.
4
Modelling the emergence of influenza drug resistance: The roles of surface proteins, the immune response and antiviral mechanisms.流感病毒耐药性产生的模型构建:表面蛋白、免疫反应及抗病毒机制的作用
PLoS One. 2017 Jul 10;12(7):e0180582. doi: 10.1371/journal.pone.0180582. eCollection 2017.
5
Drug Susceptibility and Viral Fitness of HIV-1 with Integrase Strand Transfer Inhibitor Resistance Substitution Q148R or N155H in Combination with Nucleoside/Nucleotide Reverse Transcriptase Inhibitor Resistance Substitutions.具有整合酶链转移抑制剂耐药性替代Q148R或N155H并与核苷/核苷酸逆转录酶抑制剂耐药性替代联合存在的HIV-1的药物敏感性和病毒适应性
Antimicrob Agents Chemother. 2015 Nov 16;60(2):757-65. doi: 10.1128/AAC.02096-15. Print 2016 Feb.
6
Reduced viral fitness and lack of cross-class resistance with integrase strand transfer inhibitor and nucleoside reverse transcriptase inhibitor resistance mutations.病毒适应性降低,且对整合酶链转移抑制剂和核苷类逆转录酶抑制剂耐药突变无交叉耐药性。
Antimicrob Agents Chemother. 2015;59(6):3441-9. doi: 10.1128/AAC.00040-15. Epub 2015 Mar 30.
7
Viral envelope is a major determinant of enhanced fitness of a multidrug-resistant HIV-1 variant.病毒包膜是多重耐药性HIV-1变体适应性增强的主要决定因素。
J Acquir Immune Defic Syndr. 2015 Apr 15;68(5):487-94. doi: 10.1097/QAI.0000000000000524.
8
Impact of mutations in highly conserved amino acids of the HIV-1 Gag-p24 and Env-gp120 proteins on viral replication in different genetic backgrounds.HIV-1 Gag-p24和Env-gp120蛋白高度保守氨基酸突变对不同遗传背景下病毒复制的影响。
PLoS One. 2014 Apr 8;9(4):e94240. doi: 10.1371/journal.pone.0094240. eCollection 2014.
9
Factors affecting relative fitness measurements in pairwise competition assays of human immunodeficiency viruses.影响人类免疫缺陷病毒成对竞争分析中相对适合度测量的因素。
J Virol Methods. 2013 Dec;194(1-2):7-13. doi: 10.1016/j.jviromet.2013.07.062. Epub 2013 Aug 8.
10
Fitness costs of mutations at the HIV-1 capsid hexamerization interface.HIV-1 衣壳六聚体界面突变的适应代价。
PLoS One. 2013 Jun 13;8(6):e66065. doi: 10.1371/journal.pone.0066065. Print 2013.

本文引用的文献

1
Procedures for reliable estimation of viral fitness from time-series data.从时间序列数据可靠估计病毒适应性的方法。
Proc Biol Sci. 2002 Sep 22;269(1503):1887-93. doi: 10.1098/rspb.2002.2097.
2
Estimating relative fitness in viral competition experiments.在病毒竞争实验中估计相对适应性。
J Virol. 2000 Dec;74(23):11067-72. doi: 10.1128/jvi.74.23.11067-11072.2000.
3
Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: virus fitness in the absence and in the presence of drug.追溯人类免疫缺陷病毒1型对蛋白酶抑制剂耐药性的进化途径:药物不存在和存在时的病毒适应性。
J Virol. 2000 Sep;74(18):8524-31. doi: 10.1128/jvi.74.18.8524-8531.2000.
4
Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy.在次优治疗期间由于获得补偿性突变导致耐药性HIV-1蛋白酶适应性增加。
AIDS. 1999 Dec 3;13(17):2349-59. doi: 10.1097/00002030-199912030-00006.
5
The P236L delavirdine-resistant human immunodeficiency virus type 1 mutant is replication defective and demonstrates alterations in both RNA 5'-end- and DNA 3'-end-directed RNase H activities.P236L地拉韦定耐药的1型人类免疫缺陷病毒突变体复制存在缺陷,并且在RNA 5'端和DNA 3'端导向的核糖核酸酶H活性方面均表现出改变。
J Virol. 1999 Jul;73(7):5803-13. doi: 10.1128/JVI.73.7.5803-5813.1999.
6
Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1.1型人类免疫缺陷病毒蛋白酶抑制剂耐药突变体的复制适应性
J Virol. 1999 May;73(5):3744-52. doi: 10.1128/JVI.73.5.3744-3752.1999.
7
Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type 1 isolates in vitro.齐多夫定耐药的1型人类免疫缺陷病毒分离株在体外的相对复制适应性
J Virol. 1998 May;72(5):3773-8. doi: 10.1128/JVI.72.5.3773-3778.1998.
8
Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215.1型人类免疫缺陷病毒亚群在逆转录酶密码子41和215处存在差异,其体内适应性具有广泛的谱系。
J Virol. 1997 Jun;71(6):4479-84. doi: 10.1128/JVI.71.6.4479-4484.1997.
9
Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors.对蛋白酶抑制剂具有高水平抗性的1型人类免疫缺陷病毒变体的适应性受损。
J Virol. 1997 Feb;71(2):1089-96. doi: 10.1128/JVI.71.2.1089-1096.1997.
10
Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase.人类免疫缺陷病毒在体内的适应性:基于逆转录酶第215位密码子单个齐多夫定耐药性突变的计算。
J Virol. 1996 Aug;70(8):5662-4. doi: 10.1128/JVI.70.8.5662-5664.1996.